Literature DB >> 8884147

Tachyphylaxis to histamine-induced wheal suppression by topical 0.05% clobetasol propionate in normal versus croton oil-induced dermatitic skin.

S Singh1, A Gupta, S S Pandey, G Singh.   

Abstract

BACKGROUND: Patients often tell about reduced effectiveness of topical steroids on repeated use. Tachyphylaxis to these agents has been demonstrated in humans for vasoconstriction and histamine-induced wheal suppression in normal skin, but not in diseased skin. Relevance of these data to diseased skin is not clear. Further, the clinical impression does not appear to match tachyphylaxis shown in normal skin with regard to the time course.
OBJECTIVES: To examine whether tachyphylaxis to histamine-induced wheal suppression by a topical steroid occurs in dermatitic skin and to determine its time course vis-à-vis normal skin.
METHODS: Pharmacodynamic response to 0.05% clobetasol propionate applied daily under occlusion was measured by histamine-induced wheal suppression assay in 10 individuals. This test was performed on a steroid-treated normal site, on a steroid-treated site where dermatitis was induced by occlusive application of 40% croton oil, and on a vehicle-treated site in each individual at different intervals up to 14 days.
RESULTS: Suppression of wheal volume started from second day in steroid-treated sites. There was significant difference in the wheal volume in steroid treated normal vs. dermatitic sites from day 2 to day 10. Maximum wheal suppression occurred earlier in dermatitic skin (day 4 vs. day 6). After this, the volume of wheal started increasing and became equal to control (complete tolerance) on 12th day in dermatitic skin and on 14th day in normal skin.
CONCLUSIONS: Time courses of tachyphylaxis to the action of 0.05% clobetasol propionate were significantly different in normal skin and dermatitic skin. Complete tolerance occurred earlier in dermatitic skin compared to normal skin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8884147     DOI: 10.1159/000246225

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  6 in total

1.  Inhibition by glucocorticoids of the mast cell-dependent weal and flare response in human skin in vivo.

Authors:  Z A Cole; G F Clough; M K Church
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Topical therapies for pruritus.

Authors:  Sarina B Elmariah; Ethan A Lerner
Journal:  Semin Cutan Med Surg       Date:  2011-06

Review 3.  Therapeutic effectiveness of alternative medications in oral lichen planus: A systematic review.

Authors:  Jayanth Kumar Vadivel; Devaraj Ezhilarasan; Meera Govindarajan; Elangovan Somasundaram
Journal:  J Oral Maxillofac Pathol       Date:  2020-09-09

Review 4.  Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.

Authors:  Sean Yilong Tan; Nisha Suyien Chandran; Ellie Ci-En Choi
Journal:  Clin Drug Investig       Date:  2021-08-18       Impact factor: 2.859

5.  The sensitive skin syndrome.

Authors:  Hadar Lev-Tov; Howard I Maibach
Journal:  Indian J Dermatol       Date:  2012-11       Impact factor: 1.494

6.  Important role of kallikrein 6 for the development of keratinocyte proliferative resistance to topical glucocorticoids.

Authors:  Mari Kishibe; Gleb Baida; Pankaj Bhalla; Robert M Lavker; Bethanee Schlosser; Sin Iinuma; Shigetaka Yoshida; Joel T Dudley; Irina Budunova
Journal:  Oncotarget       Date:  2016-10-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.